CTT Pharmaceutical Holdings (CTT Pharmaceutical Holdings) EBIT per Share : $-0.06 (TTM As of Jun. 2018)

View and export this data going back to . Start your Free Trial

What is CTT Pharmaceutical Holdings EBIT per Share?

CTT Pharmaceutical Holdings's EBIT per Share for the three months ended in Jun. 2018 was $-0.05. Its EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2018 was $-0.06.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for CTT Pharmaceutical Holdings's EBIT per Share or its related term are showing as below:

CTTH's 3-Year EBIT Growth Rate is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 7.5
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

CTT Pharmaceutical Holdings's EBIT for the three months ended in Jun. 2018 was $-1.09 Mil.

CTT Pharmaceutical Holdings EBIT per Share Historical Data

The historical data trend for CTT Pharmaceutical Holdings's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CTT Pharmaceutical Holdings EBIT per Share Chart

CTT Pharmaceutical Holdings Annual Data

Trend

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

EBIT per Share

Get a 7-Day Free Trial

-0.80

-1.16

-0.04

-0.07

CTT Pharmaceutical Holdings Quarterly Data
	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Mar17	Jun17	Mar18	Jun18
EBIT per Share	Get a 7-Day Free Trial															-0.01	-	-0.01	-0.01	-0.05

CTT Pharmaceutical Holdings EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

CTT Pharmaceutical Holdings's EBIT per Share for the fiscal year that ended in Dec. 2015 is calculated as

	EBIT per Share		(A: Dec. 2015 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-1.446	/	20.867
=	-0.07

CTT Pharmaceutical Holdings's EBIT per Share for the quarter that ended in Jun. 2018 is calculated as

	EBIT per Share		(Q: Jun. 2018 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-1.09	/	21.3193
=	-0.05

EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.06

CTT Pharmaceutical Holdings (OTCPK:CTTH) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

CTT Pharmaceutical Holdings EBIT per Share Related Terms

Thank you for viewing the detailed overview of CTT Pharmaceutical Holdings's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

CTT Pharmaceutical Holdings (CTT Pharmaceutical Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CTT Pharmaceutical Holdings Inc (OTCPK:CTTH) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

1100 – 1111 Melville Street, Vancouver, BC, CAN, V6E 3V6

Website

https://www.cttpharmaceuticals.com

CTT Pharmaceutical Holdings Inc is a development stage company specializing in drug delivery systems technology within the pharmaceutical industry. It focuses on fast-dissolving drug delivery systems through the development of oral delivery thin wafers. The thin wafers are infused with both natural and synthetic cannabis extracts to deliver treatment as an alternative to smoking and ingestion. Its products include Medwafe, Cannawafe, Vetwafe, and others.

Executives